C. R. Bard, Inc. v. Angiodynamics, Inc.

156 F. Supp. 3d 540, 2016 U.S. Dist. LEXIS 3324, 2016 WL 153033
District Court, D. Delaware·Decided January 12, 2016·No. Civ. No. 15-218-SLR·Published·Cited by 1 cases

Opinion

MEMORANDUM OPINION

ROBINSON, District Judge

I. INTRODUCTION

On March 10, 2015, plaintiffs C. R. Bard, Inc. and Bard Peripheral Vascular, Inc. (“collectively, “plaintiffs”) filed this patent suit against defendant, alleging infringement of U.S. Patent Nos. 8,475,417 (the “’417 patent”), 8,545,460 (the “’460 patent”), and 8,805,478 (the “’478 patent”) (collectively, “the patents-in-suit”) by certain implantable power-injectable port products, including Smart Port® products. (D.I. 1) Presently before the court are defendant’s motion to dismiss (D.I. 9) and motion to transfer (D.I. 11), as well as plaintiffs’ motion for leave to file a sur-reply in response to defendant’s reply in support of its motion to dismiss (D.I. 22). [544] The court has jurisdiction pursuant to 28 U.S.C. §§ 1331 and 1338(a).

11. BACKGROUND

C. R. Bard, Inc. is a corporation organized and existing under the laws of the State of New Jersey with its principal place of business in Murray Hill, New Jersey. Bard Peripheral Vascular, Inc. (a subsidiary of C. R. Bard, Inc.) is a corporation organized and existing under the laws of the State of Arizona with its principal place of business in Tempe, Arizona. Defendant is a corporation organized under the laws of the State of Delaware with its principal place of business in -Latham, New York. (D.1.1 at, ¶¶ 3-5)

The ’417 patent is titled “Assemblies for Identifying a Power Injectable Access Port” and issued July 2, 2013. The ’460 patent is titled “Infusion Apparatuses ánd Related Methods” and issued October 1, 2013. The ’478 patent is titled “Methods of Performing a Power Injection Procedure Including Identifying Features of a Subcutaneously Implanted Access Port for Delivery of Contrast Media” and issued August 12, 2014. Plaintiffs assert infringement of claims 8, 12, and 13 of the ’417 patent, claims 1, 2, and 4 of the ’460 patent, and claims 1, 3, 5, 8, 9, and 11 of the ’478 patent. (D.I. 1 at ¶¶ 19, 27, 35)

III. MOTION TO TRANSFER
A. Standard

Section 1404(a) of Title 28 of the United States Code grants district courts the authority to transfer venue “[f]or the convenience of parties and witnesses, in the interests of justice ... to any other district or division where it might have been brought.” 28 U.S.C. § 1404(a). Much has been written about the legal standard for motions to transfer under 28 U.S.C. § 1404(a). See, e.g., In re Link_A_Media Devices Corp,, 662 F.3d 1221 (Fed.Cir.2011); Jumara v. State Farm Ins. Co., 55 F.3d 873 (3d Cir.1995); Helicos Biosciences Corp. v. Illumina, Inc., 858 F.Supp.2d 367 (D.Del.2012).

Referring specifically to the analytical framework described in Helicos, the court starts with the premise that a defendant’s state of incorporation has always been “a predictable, legitimate venue for bringing suit” and that “a plaintiff, as the injured party, generally ha[s] been ‘accorded [the] privilege of bringing an action where he chooses.’ ” 858 F.Supp.2d at 371 (quoting Norwood v. Kirkpatrick, 349 U.S. 29, 31, 75 S.Ct. 544, 99 L.Ed. 789 (1955)). Indeed, the Third Circuit in Jumara reminds the reader that “[t]he burden of establishing the need for transfer ... rests with the movant” and that, “in ruling on defendants’ motion, the plaintiffs choice of venue should not be lightly disturbed.” 55 F.3d at 879 (citation omitted).

The Third Circuit goes on to recognize that,

[i]n ruling on § 1404(a) motions, courts have not limited them consideration to the three enumerated factors in § 1404(a) (convenience of parties, convenience of witnesses, or interests of justice), and, indeed, commentators have called on the courts to “consider all relevant factors to determine whether on balance the litigation would more conveniently proceed and the interests of justice be better served by transfer to a different forum.”

Id. (citation omitted). The Court then describes some of the “many variants of the private and public interests protected by the language of § 1404(a).” Id.

The private interests have included: plaintiffs forum of preference as manifested in the original choice; the defendant’s preference; whether the claim arose elsewhere; the convenience of the parties as indicated by their relative physical and financial condition; the convenience of the witnesses — but only to [545] the extent that the witnesses may actually be unavailable for trial in one of the fora; and the location of books and records (similarly limited to the extent that the files could not be produced in the alternative forum).
The public interests have included: the enforceability of the judgment; practical considerations that could make the trial easy, expeditious, or inexpensive; the relative administrative difficulty in the two fora resulting from court congestion; the local interest in deciding local controversies at home; the public policies of the fora; and the familiarity of the trial judge with the applicable state law in diversity cases.

Id. (citations omitted) (emphasis added).

B. Analysis

With the above “jurisdictional guideposts” in mind, the court turns to the “difficult issue of federal comity” that transfer motions present. E.E.O.C. v. Univ. of Pa., 850 F.2d 969, 976 (3d Cir.1988). Plaintiffs do not challenge that venue would also be proper in the District of Utah. As such, the court does not address this further. See 28 U.S.C. § 1404(a); (D.I. 16)

Free access — add to your briefcase to read the full text and ask questions with AI

C. R. Bard, Inc. v. Angiodynamics, Inc., 156 F. Supp. 3d 540, 2016 U.S. Dist. LEXIS 3324, 2016 WL 153033 (D. Del. 2016).

156 F. Supp. 3d 540 (C. R. Bard, Inc. v. Angiodynamics, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

C R Bard Inc. v. Angiodynamics, Inc.
979 F.3d 1372 (Federal Circuit, 2020)